Evidence map›Paper›PMID 29757907›Full record

ReviewTransplantation2018

T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Elizabeth F Wallin

Open access · greenAbstract readReview
In one paragraph

Review in Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. The diagnostic role of PD-1Journal of clinical laboratory analysis · 2022
    Article
  4. Article
  5. Current Advances in Follicular Regulatory T-Cell Biology.Critical reviews in immunology · 2022
    Review
  6. Article
  7. Review
  8. Germinal Centre Shutdown.Frontiers in immunology · 2021
    Review
  9. Therapies for Chronic Allograft Rejection.Frontiers in pharmacology · 2021
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Elizabeth F WallinTransplant Research Immunology Group, Nuffield Department of Surgical Sciences, Level 6 John Radcliffe Hospital, Oxford.
John Radcliffe Hospital · GB

Funding

Medical Research Council MR/L000539/1
6 · The paper itself

Abstract

De novo donor-specific antibody (DSA) formation is a major problem in transplantation, and associated with long-term graft decline and loss as well as sensitization, limiting future transplant options. Forming high-affinity, long-lived antibody responses involves a process called the germinal center (GC) reaction, and requires interaction between several cell types, including GC B cells, T follicular helper (Tfh) and T follicular regulatory (Tfr) cells. T follicular regulatory cells are an essential component of the GC reaction, limiting its size and reducing nonspecific or self-reactive responses.An imbalance between helper function and regulatory function can lead to excessive antibody production. High proportions of Tfh cells have been associated with DSA formation in transplantation; therefore, Tfr cells are likely to play an important role in limiting DSA production. Understanding the signals that govern Tfr cell development and the balance between helper and regulatory function within the GC is key to understanding how these cells might be manipulated to reduce the risk of DSA development.This review discusses the development and function of Tfr cells and their relevance to transplantation. In particular how current and future immunosuppressive strategies might allow us to skew the ratio between Tfr and Tfh cells to increase or decrease the risk of de novo DSA formation.

Indexed as

AbataceptAntibody FormationBiomarkersB-LymphocytesCell DifferentiationGerminal CenterGraft RejectionHumansImmunosuppressive AgentsIsoantibodiesT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryTransplantationAbataceptBiomarkersImmunosuppressive AgentsIsoantibodies

Identifiers

PMID29757907
PMCPMC6124648
OpenAlexW2799597866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.